442 related articles for article (PubMed ID: 1631795)
21. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
Komuro Y; Imanishi N; Uchida M; Morooka S
Mol Pharmacol; 1990 Sep; 38(3):378-84. PubMed ID: 2402227
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of [3H]platelet activating factor (PAF) binding by Zn2+: a possible explanation for its specific PAF antiaggregating effects in human platelets.
Nunez D; Kumar R; Hanahan DJ
Arch Biochem Biophys; 1989 Aug; 272(2):466-75. PubMed ID: 2502069
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of platelet aggregation by shikonin derivatives isolated from Arnebia euchroma.
Chang YS; Kuo SC; Weng SH; Jan SC; Ko FN; Teng CM
Planta Med; 1993 Oct; 59(5):401-4. PubMed ID: 8255930
[TBL] [Abstract][Full Text] [Related]
24. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
[TBL] [Abstract][Full Text] [Related]
25. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation.
Chang GT; Kang SK; Kim JH; Chung KH; Chang YC; Kim CH
J Ethnopharmacol; 2005 Dec; 102(3):430-9. PubMed ID: 16125889
[TBL] [Abstract][Full Text] [Related]
28. [Modulating effects of adenosine on the process of human platelet activation].
Prokudin VIu; Melkova OM; Karaulov AV; Porodenko NV
Biull Eksp Biol Med; 1992 Jun; 113(6):606-8. PubMed ID: 1446028
[TBL] [Abstract][Full Text] [Related]
29. [Inhibitory effect of TBN on platelet aggregation in rabbit].
Xu CL; Shan LC; Sun YW; Wang YQ
Zhong Yao Cai; 2010 Sep; 33(9):1450-3. PubMed ID: 21243778
[TBL] [Abstract][Full Text] [Related]
30. Effect of fast-food Mediterranean-type diet on type 2 diabetics and healthy human subjects' platelet aggregation.
Karantonis HC; Fragopoulou E; Antonopoulou S; Rementzis J; Phenekos C; Demopoulos CA
Diabetes Res Clin Pract; 2006 Apr; 72(1):33-41. PubMed ID: 16236380
[TBL] [Abstract][Full Text] [Related]
31. Modulation of platelet and leucocyte function by a Chinese herbal formulation as compared with conventional antiplatelet agents.
Zhao L; Gaudry L; Dunkley S; Brighton T; Guo ZX; Ye ZL; Luo RZ; Chesterman CN
Platelets; 2008 Feb; 19(1):24-31. PubMed ID: 18231935
[TBL] [Abstract][Full Text] [Related]
32. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
[TBL] [Abstract][Full Text] [Related]
33. Activation of rabbit platelets by platelet-activating factor derived from IgE-sensitized basophils. Characteristics of the aggregation and its dissociation from secretion.
Henson PM
J Clin Invest; 1977 Aug; 60(2):481-90. PubMed ID: 874106
[TBL] [Abstract][Full Text] [Related]
34. Antiplatelet aggregation activity of diterpene alkaloids from Spiraea japonica.
Li L; Shen YM; Yang XS; Zuo GY; Shen ZQ; Chen ZH; Hao XJ
Eur J Pharmacol; 2002 Aug; 449(1-2):23-8. PubMed ID: 12163102
[TBL] [Abstract][Full Text] [Related]
35. Exogenous diacylglycerols synergize with PAF with human platelets, but inhibit PAF-induced responses of rabbit platelets.
Packham MA; Ruben DH; Rand ML
J Lipid Mediat Cell Signal; 1996 Dec; 15(1):69-87. PubMed ID: 9029375
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of sulfur-containing compounds in Scorodocarpus borneensis Becc. on the aggregation of rabbit platelets.
Lim H; Kubota K; Kobayashi A; Seki T; Ariga T
Biosci Biotechnol Biochem; 1999 Feb; 63(2):298-301. PubMed ID: 10192909
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of collagen-induced platelet aggregation and adhesion by a pseudocyanide derivative of avicine isolated from Zanthoxylum integrifoliolum Merr.
Ko FN; Hsiao G; Chen IS; Wu SJ; Teng CM
Biochem Pharmacol; 1993 Oct; 46(7):1165-73. PubMed ID: 8216367
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological properties of YM264, a potent and orally active antagonist of platelet-activating factor.
Yamada T; Tomioka K; Saito M; Horie M; Mase T; Hara H; Nagaoka H
Arch Int Pharmacodyn Ther; 1990; 308():123-36. PubMed ID: 2099131
[TBL] [Abstract][Full Text] [Related]
39. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
Ammit AJ; O'Neill C
Lipids; 1991 Dec; 26(12):1189-92. PubMed ID: 1668116
[TBL] [Abstract][Full Text] [Related]
40. Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet.
Terashita Z; Imura Y; Nishikawa K
Biochem Pharmacol; 1985 May; 34(9):1491-5. PubMed ID: 2986648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
